Clinical trial
A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed…
NCT00110435 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00110435 |
|---|---|
| Title | A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077) |
| Official title | A Multicenter, Randomized, Double-blind, Parallel Group, 6-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet Versus Atorvastatin in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypercholesterolemia |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus, Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | MK0653A, ezetimibe (+) simvastatin, Duration of Treatment: 4 wk placebo run in then 6 wk active, Comparator: atorvastatin |
| Enrollment | 1,229 |
| Start date | May 1, 2005 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | May 10, 2005 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: